Fighting melanoma with your own immune cells: new trial challenges chemotherapy
NCT ID NCT07406724
Summary
This study is testing whether a personalized immune cell therapy works better than chemotherapy for advanced melanoma. Researchers will compare a one-time treatment using patients' own tumor-fighting immune cells against standard chemotherapy drugs. The trial will enroll 90 adults whose melanoma has worsened despite previous treatments, including immunotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (EXCLUDING UVEAL MELANOMA) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.